| Literature DB >> 32766200 |
Tekeda F Ferguson1,2, Alaina Beauchamp2, Erika M Rosen1,2, A Nicole Ray1,3, Katherine P Theall1,4, Nicholas W Gilpin1,5, Patricia E Molina1,5, Scott Edwards1,5.
Abstract
Objectives: There is limited information about the applicability and effectiveness of tobacco and illicit drug use interventions in urban and racial/ethnic minority youth, a population with great need for prevention of alcohol and drug use. We pilot-tested the feasibility of a behavioral intervention to reduce alcohol, tobacco, and illicit drug use among urban young adults in New Orleans, Louisiana. Study Design: The 12-week intervention pilot project was developed to be implemented at a community-based social service organization that provides educational, juvenile justice-related case management, and mentoring services to youth with substance use and incarceration histories.Entities:
Keywords: alcohol intervention; drug intervention; drugs and tobacco in youth; urban youth; youth intervention
Year: 2020 PMID: 32766200 PMCID: PMC7379478 DOI: 10.3389/fpubh.2020.00314
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Weekly session topics of the Comprehensive Alcohol-HIV/AIDS Research Center (CARC), Toward No Drug Abuse (TND) 12-week pilot program and mean session evaluation score from participants.
| Week 1: Introduction and Pretest | Introduce project TND, explain study, consent, and consenting individuals complete the pre-intervention survey. | Tier 1: $10 | |
| Week 2: Active listening and stereotyping | Identify effective/ineffective communication strategies. Understand what stereotyping is and the implications of group-labeling. Emphasis will be placed on understanding the concept of “self-fulfilling prophecy.” | 9.71 | Tier 2: $12 |
| Week 3: Myths and denials | Understanding how beliefs are used to justify actions and recognizing the “myths” of drug abuse. | 9.89 | |
| Week 4: Chemical dependency | Course of negative consequences associated with chemical dependency; information tailored to include local drug use trends and data. | 9.64 | Tier 3: $14 |
| Week 5: Talk show (psychodrama) | Role-play as television talk show guests who are affected by drug abuse; explore the impact of drug abuse on family and friends as well as the substance abusing individual. | 9.00 | |
| Week 6: Marijuana panel and tobacco basketball | Familiarize youth with basic information about tobacco use and trends (game format). | 9.20 | Tier 4: $16 |
| Week 7: Stress, health, and goals | Identify and define proactive and negative coping strategies and discuss how stress and drug use impacts health. | 9.75 | |
| Week 8: Self-Control | Learn about behavior-matching in the context of self-control; identify passive, aggressive, and assertive communication skills. Develop assertive communication skills. | 9.20 | Tier 5: $18 |
| Week 9: Thought and behavior loops | Learn about thought process & behavior loops and how to recognize these patterns; e.g., violent behavior is a consequence of negative thoughts as a response to frustration/anger. | 9.40 | |
| Week 10: Perspectives | Identify cognitive dissonance and discuss strategies to align attitudes/behaviors. | 9.80 | Tier 6: $20 |
| Week 11: Decision-making and commitment | Think through the options with respect to using drugs & violence, and outline life goals. Final activity will include signing a personal commitment statement as defined by participants for themselves. | 9.40 | |
| Week 12: Post-test and wrap-up | Complete the post-intervention survey. Participants received a certificate of completion recognizing their participation and mastery of skills and information presented in the intervention. | $20 |
Demographics and lifetime self-report of ever-use of alcohol, tobacco, and marijuana among Project Toward No Drug Abuse (TND) pilot study participants, 2016 National Institute of Drug Abuse-Monitoring the Future (NIDA-MTF) African American (AA) participants from Southern Metropolitan Statistical Areas (MSAs), and all AA NIDA-MTF participants.
| Age (mean s.d.) | 18.3 (1.3) | – | – | |
| Age group | % (n) | % (n) | % (n) | |
| Under 18 | 36.7 (11) | 38.1 (321) | 38.2 (648) | |
| ≥ 18 | 63.3 (19) | 61.6 (519) | 61.6 (1,047) | |
| Missing | – | 0.3 (2) | 0.2 (4) | |
| Male | 63.3 (19) | 42.4 (357) | 44.8 (761) | |
| Female | 36.7 (11) | 51.5 (434) | 48.4 (822) | |
| Missing | – | 6.1 (51) | 6.8 (116) | |
| Black | 93.3 (28) | 100.0 (842) | 100.0 (1,699) | |
| White | 3.3 (1) | – | – | |
| Other | 3.3 (1) | – | – | |
| Alcohol | 73.3 (22) | 39.3 (331) | 40.6 (689) | |
| Cigarettes | 66.7 (20) | 13.2 (111) | 17.0 (289) | |
| Vapor product | 43.3 (13) | 0.06 (47) | 0.05 (84) | |
| Marijuana | 83.3 (25) | 39.4 (332) | 40.3 (684) | |
weighted frequencies;
indicated p < 0.0001.
Baseline number of times in the young adult's lifetime that substances were used by age group and sex among the Comprehensive Alcohol-HIV/AIDS Research Center (CARC) Project Toward No Drug Abuse (TND) pilot study participants, n = 30.
| Alcohol | 26.7 (8) | 36.7 (11) | 3.3 (1) | 16.7 (5) | 3.3 (1) | 13.3 (4) |
| | 27.3 (3) | 36.4 (4) | – | 18.2 (2) | 9.1 (1) | 9.1 (1) |
| | 26.3 (5) | 36.8 (7) | 5.3 (1) | 15.8 (3) | – | 15.8 (3) |
| | 42.1 (8) | 31.6 (6) | – | 15.8 (3) | – | 10.5 (2) |
| | – | 45.5 (5) | 9.1 (1) | 18.2 (2) | 9.1 (1) | 18.2 (2) |
| Cigarettes | 33.3 (10) | 20.0 (6) | 3.3 (1) | 10.0 (3) | 3.3 (1) | 30.0 (9) |
| | 45.5 (5) | 18.2 (2) | 9.1 (1) | 9.1 (1) | – | 18.2 (2) |
| | 26.3 (5) | 21.1 (4) | – | 10.5 (2) | 5.3 (1) | 36.8 (7) |
| | 31.6 (6) | 21.1 (4) | 5.3 (1) | 5.3 (1) | 5.3 (1) | 31.6 (6) |
| | 36.4 (4) | 18.2 (2) | - | 18.2 (2) | - | 27.3 (3) |
| Cigars or cigarillos | 66.7 (20) | 10.0 (3) | 10.0 (3) | 3.3 (1) | 3.3 (1) | 6.7 (2) |
| | 72.7 (8) | 9.1 (1) | 18.2 (2) | – | – | – |
| | 63.2 (12) | 10.5 (2) | 5.3 (1) | 5.3 (1) | 5.3 (1) | 10.5 (2) |
| | 68.4 (13) | 5.3 (1) | 5.3 (1) | 5.3 (1) | 5.3 (1) | 10.5 (2) |
| | 63.6 (7) | 18.2 (2) | 18.2 (2) | – | – | – |
| Vapor product | 56.7 (17) | 13.3 (4) | 13.3 (4) | 6.7 (2) | – | 10.0 (3) |
| | 63.6 (7) | 18.2 (2) | 18.2 (2) | – | – | – |
| | 52.6 (10) | 10.5 (2) | 10.5 (2) | 10.5 (2) | – | 15.8 (3) |
| | 52.6 (10) | 10.5 (2) | 21.1 (4) | 5.3 (1) | – | 10.5 (2) |
| | 63.6 (7) | 18.2 (2) | - | 9.1 (1) | – | 9.1 (1) |
| Marijuana | 16.7 (5) | 3.3 (1) | 10.0 (3) | 6.7 (2) | 10.0 (3) | 53.3 (16) |
| | 27.3 (3) | – | 27.3 (3) | 18.2 (2) | 9.1 (1) | 18.2 (2) |
| | 10.5 (2) | 5.3 (1) | – | – | 10.5 (2) | 73.7 (14) |
| | 15.8 (3) | 5.3 (1) | 10.5 (2) | 10.5 (2) | – | 57.9 (11) |
| | 18.2 (2) | – | 9.1 (1) | – | 27.3 (3) | 45.5 (5) |
| Non-prescribed prescription drugs | 76.7 (23) | 6.7 (2) | 3.3 (1) | 6.7 (2) | – | 6.7 (2) |
| | 81.8 (9) | 9.1 (1) | – | – | – | 9.1 (1) |
| | 73.7 (14) | 5.3 (1) | 5.3 (1) | 10.5 (2) | – | 5.3 (1) |
| | 68.4 (13) | 10.5 (2) | 5.3 (1) | 10.5 (2) | – | 5.3 (1) |
| | 90.9 (10) | – | – | – | – | 9.1 (1) |
Pre and post-intervention estimates of alcohol, tobacco, marijuana, and other drug use in the last 30 days among Comprehensive Alcohol-HIV/AIDS Research Center (CARC) Project Toward No Drug Abuse (TND) pilot study participants.
| | 50.0 (15) | 50.0 (15) | – | – | – | – |
| | 75.0 (6) | 25.0 (2) | – | – | – | – |
| | 62.5 (5) | 37.5 (3) | – | – | – | – |
| | 82.3 (632) | 12.9 (99) | 4.4 (34) | 0.1 (1) | – | 0.2 (2) |
| | 79.5 (1,226) | 13.5 (208) | 5.6 (87) | 0.6 (10) | 0.3 (4) | 0.5 (8) |
| | 56.7 (17) | 13.3 (4) | – | 13.3 (4) | 6.7 (2) | 10.0 (3) |
| | 75.0 (6) | 12.5 (1) | – | – | 12.5 (1) | – |
| | 87.5 (7) | 12.5 (1) | – | – | – | – |
| | 40.0 (12) | 20.0 (6) | – | 3.3 (1) | 6.6 (2) | 30.0 (9) |
| | 50.0 (4) | 37.5 (3) | – | – | – | 12.5 (1) |
| | 25.0 (2) | 37.5 (3) | – | 12.5 (1) | 12.5 (1) | 12.5 (1) |
| | 77.5 (606) | 7.0 (55) | 6.1 (48) | 3.1 (24) | 2.4 (19) | 3.8 (30) |
| | 76.3 (1,213) | 7.4 (117) | 6.2 (99) | 2.8 (45) | 2.2 (35) | 5.0 (80) |
No reported pre- or post-intervention use of cocaine, hallucinogens, stimulants, or inhalants in the past 30 days. Change in 30-day use not statistically significant between pre- and post-intervention, assessed by paired t-test.